As we grow older, our brain tends to shrink. We become increasingly
vulnerable to dementia and stroke, two common disorders in the elderly that have
great impact on brain functioning and the way people live their lives. The burden of
these diseases will rapidly grow over the coming years as a result of aging populations
worldwide. Currently, dementia (11.2%) and stroke (9.5%) already contribute
substantially to the number of years lived with disability of people aged 60 and older;
this is considerably more than the years of disability caused by cardiovascular disease
(5.0%) or by all forms of cancer (2.4%) together. Since few therapeutic possibilities
exist for these neurological diseases in the elderly, effective prevention strategies are
urgently needed.
In order to develop successful approaches to prevent dementia and stroke, it is
crucial to explore the early presymptomatic phases of these diseases. Markers that
enable us to detect disease in an early stage before the clinical syndromes of dementia
and stroke become apparent are strongly needed to gain more insight in the causes of
dementia and stroke, to identify persons who will develop these diseases, and to
provide opportunities to alter or stop the disease process. Magnetic resonance imaging
(MRI) has proven to be a very suitable technique for the investigation of these
presymptomatic phases as it offers detailed information about presymptomatic
pathology in the brain without exposure to radiation.
http://repub.eur.nl/res/pub/31197/120119_Poels%2C%20Mari%C3%ABlle%20Martina%20Francisca.pdf
http://repub.eur.nl/res/pub/31197/120119_Poels%2C%20Mari%C3%ABlle%20Martina%20Francisca.pdf
No comments:
Post a Comment